VERONICA BAKER: Open Payments
NPI 1164865341 · BEACHWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 44 payments from 12 companies in 2025. Trend: 2023 $1,418 · 2024 $752 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $148 |
| Otsuka America Pharmaceutical, Inc. | 6 | $120 |
| Neos Therapeutics, LP | 4 | $80 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Alkermes, Inc. | 1 | $18 |
| TMS NeuroHealth Centers Inc. | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Adzenys XR-ODT, Auvelity, FANAPT, AUSTEDO XR, SPRAVATO.
Industry payments across OH — which companies pay providers there.
